BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Europe is experiencing a renaissance in GPCR-targeted drug dis
 covery. The unprecedented commercial success of GLP-1 receptor agonists i
 n obesity has reignited investment\, innovation\, and clinical exploratio
 n across the GPCR space. With major deals such as Eli Lilly’s $1.3 billio
 n collaboration to advance small-molecule GPCR therapeutics using AI- and
  ML-powered platforms\, momentum is building fast\, making 2025 a pivotal
  year to be part of this rapidly evolving field.\n\nReturning as the only
  meeting dedicated exclusively to GPCR drug discovery and development in 
 Europe\, the 2nd Annual GPCR-Targeted Drug Discovery Summit Europe brings
  together the brightest minds in biopharma to translate this momentum int
 o actionable strategies.\n\nFrom expanding pipelines in cardiometabolic d
 isease\, neuroscience\, oncology\, and inflammation\, to tackling biased 
 signalling and optimising pharmacological modulation\, this summit delive
 rs the breadth and depth you need to progress differentiated\, best-in-cl
 ass GPCR-targeting drugs.\n\nWhether you’re looking to identify new targe
 ts\, enhance your discovery toolkit\, or forge critical collaborations\, 
 this is your opportunity to stay ahead of the curve as biopharma redefine
 s the druggable paradigm with next-generation GPCR therapeutics.\n\nURLs:
 Website: https://go.evvnt.com/3246067-0?pid=185Tickets: https://go.evvnt.
 com/3246067-1?pid=185Brochure: https://go.evvnt.com/3246067-3?pid=185\n\n
 Date and Time: On Tue\, 09 Dec 2025 08:00 - Thu\, 11 Dec 2025 15:00\n\nVe
 nue Details: Park Plaza Victoria London\, 239 Vauxhall Bridge Rd\, Pimlic
 o\, London\, SW1V 1EQ\, United Kingdom\n\nCategory: Conferences | Science
 \, Health and Medicine | Pharmaceuticals\n\nPrices:Conference + 2 Worksho
 ps (Drug Developer Pricing): GBP 3597.00\,Conference + 1 Workshop (Drug D
 eveloper Pricing): GBP 3098.00\,Conference Only (Drug Developer Pricing):
  GBP 2599.00\,Conference + 2 Workshops (Academic Pricing): GBP 2997.00\,C
 onference + 1 Workshop (Academic Pricing): GBP 2598.00\,Conference Only (
 Academic Pricing): GBP 2199.00\,Conference + 2 Workshops (Service Provide
 r Pricing): GBP 4297.00\,Conference + 1 Workshop (Service Provider Pricin
 g): GBP 3698.00\,Conference Only (Service Provider Pricing): GBP 3099.00\
 n\nSpeakers: Shuguang Yuan\, Co-Founder\, Alphamol Science\, Juan-Carlos 
 Mobarec\, Head of Computational Structural Biology\, AstraZeneca\, Dietma
 r Weichert\, Principal Scientist\, Boehringer Ingelheim\, Christel Menet\
 , Chief Scientific Officer\, Confo Therapeutics\, Stephan Schann\, Chief 
 Scientific Officer\, Domain Therapeutics\, Lewis Vidler\, Senior Director
  - Structure Based Drug Design\, Eli Lilly\, Alejandra Tomas\, Head of Se
 ction of Cell Biology and Functional Genomics\, Imperial College London\,
  Paul Groot-Kormelink\, Associate Director in Discovery Sciences - Biomed
 ical Research\, Novartis\, Laia Malet Sanz\, Director - Medicinal Chemist
 ry\, OMass Therapeutics\, Aurore Morello\, Head of Research\, Director of
  R and D Program\, OSE Immunotherapeutics\, Irina Tikhonova\, Molecular M
 odelling Reader\, Queen's University Belfast\, Arne Christian\, Rufer Exp
 ert Scientist\, Roche\, Robin Loving\, Chief Scientific Officer\, Salipro
  Biotech\, Alexey Rak\, Head of Bio Structure and Biophysics\, Sanofi\, M
 anel Kraiem\, Chief Development Officer\, Skymab Biotherapeutics\, Chris 
 de Graaf\, Vice President - Head of Computational Drug Discovery and Data
  Science\, Structure Therapeutics\, Graeme Milligan\, Professor of Bioche
 mistry\, University of Glasgow\n
DTEND:20251211T150000
DTSTAMP:20260512T232257Z
DTSTART:20251209T080000
LOCATION:Park Plaza Victoria London\, 239 Vauxhall Bridge Rd\, Pimlico\, L
 ondon\, England\, SW1V 1EQ\,
SEQUENCE:0
SUMMARY:Europe is experiencing a renaissance in GPCR-targeted drug discove
 ry. The unprecedented commercial success of GLP-1 receptor agonists in ob
 esity ha...
UID:c2a0450c-f76c-4e15-be15-501d77015311
END:VEVENT
END:VCALENDAR
